Normal range and predictors of serum erythroferrone in infants

Fredrik Bäckström1, Anna Chmielewska1, Magnus Domellöf1

  • 1Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.

Pediatric Research
|April 17, 2023
PubMed

Insights

Erythroferrone (ERFE) levels in infants are established for the first time, showing low concentrations at birth that increase over the first year. Infant ERFE levels do not correlate with iron status, suggesting different iron regulation compared to adults.

Area of Science:

  • Pediatric Hematology
  • Iron Metabolism
  • Endocrinology

Background:

  • Erythroferrone (ERFE) is a hepcidin-regulating hormone linked to erythropoiesis and iron needs in adults.
  • Its role and concentration patterns in infants are not well understood.

Purpose of the Study:

  • To determine serum concentrations of ERFE in healthy infants during their first year of life.
  • To identify predictors of ERFE levels, including birth weight and iron supplementation.

Main Methods:

  • ERFE levels were measured in 45 normal birth weight (NBW) and 136 marginally low birth weight (LBW) infants at four time points from 6 weeks to 12 months.
  • LBW infants received either iron supplementation or placebo between 6 weeks and 6 months.

Main Results:

  • ERFE concentrations were low at birth, rising throughout the first year, with established reference ranges for NBW infants.
  • LBW infants had higher ERFE at 6 weeks but lower at 12 months compared to NBW infants; iron supplementation had minimal effect.
  • Correlations between ERFE and erythropoietic or iron status markers were weak and inconsistent in infants.

Conclusions:

  • This study provides the first normal ranges for erythroferrone in healthy infants.
  • ERFE in infants appears to be dissociated from iron status and erythropoiesis markers, unlike in adults.
  • Findings suggest distinct infant iron homeostasis regulation and highlight the need for infant-specific studies, potentially impacting anemia management.
Abstract

Related Concept Videos

Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.4K
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.4K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
25
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.4K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.0K
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
2.0K